Cyanosis screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
==Screening== | ==Screening== | ||
Guidelines for the performance of fetal echocardiograms recommend: | Guidelines for the performance of fetal echocardiograms recommend: | ||
* Color Doppler are used to identify small vessels such as the pulmonary veins, ductus venosus, and ductus arteriosus, to assess valvular competence and flow patterns, and to examine the ventricular septum for defects. | * [[Doppler|Color Doppler]] are used to identify small vessels such as the [[pulmonary veins]], [[ductus venosus]], and [[ductus arteriosus]], to assess valvular competence and flow patterns, and to examine the [[ventricular septum]] for defects. | ||
* Three-dimensional | * Three-dimensional [[echocardiography]], tissue Doppler, fetal electrocardiography, and cardiovascular [[magnetic resonance imaging]]. [14]. | ||
* When a fetal cardiac abnormality is detected, additional evaluation and follow-up are indicated. | * When a fetal cardiac abnormality is detected, additional evaluation and follow-up are indicated. | ||
* Patients who have a normal basic fetal cardiac evaluation and echocardiography generally do not require further evaluation unless there is an elevated risk of evolution of fetal heart disease later in pregnancy. | * Patients who have a normal basic fetal cardiac evaluation and echocardiography generally do not require further evaluation unless there is an elevated risk of evolution of fetal heart disease later in pregnancy. | ||
* | * Prenatal [[ultrasound]] and [[magnetic resonance imaging]] (MRI) found that [[brain]] abnormalities, delay in head growth, and brain-sparing were observed in subgroups of fetuses with [[congenital heart disease]]. 38 | ||
== Genetic assessment == | == Genetic assessment == | ||
* Fetal genetic assessment is indicated because chromosome abnormalities are common in fetuses with cardiac defects, even when isolated. | * Fetal genetic assessment is indicated because [[chromosome abnormalities]] are common in fetuses with cardiac defects, even when isolated. | ||
* The risk of fetal aneuploidy varies depending on the malformation. [14]: | * The risk of fetal [[aneuploidy]] varies depending on the malformation. [14]: | ||
* | * The [[22q11.2 deletion syndrome|22q11 deletion]] has been associated with several cardiac anomalies, including [[interrupted aortic arch]], [[truncus arteriosus]], [[ventricular septal defect]], and [[tetralogy of Fallot]]. [14]. | ||
* The two main approaches for genetic testing are: | * The two main approaches for genetic testing are: | ||
* G-banding of fetal cells obtained via amniocentesis, with fluorescent in situ hybridization (FISH) to assess for microdeletions, such as 22q11, not detectable by visual banding techniques | * [[G-banding]] of fetal cells obtained via [[amniocentesis]], with [[Fluorescent in situ hybridization|fluorescent in situ hybridization (]]FISH) to assess for [[Microdeletion|microdeletions]], such as 22q11, not detectable by visual banding techniques. | ||
* | * Chromosomal [[microarray]], which detects submicroscopic chromosomal abnormalities in 5 percent of fetuses with ultrasound-detected anomalies and a normal [[G-banding|G-band karyotype]]. | ||
* Disadvantages of [[Microarray|chromosomal microarray]] are that balanced rearrangements are not detectable and variants of unknown significance may be identified. | |||
==References== | ==References== | ||
Revision as of 16:45, 22 March 2018
|
Cyanosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cyanosis screening On the Web |
|
American Roentgen Ray Society Images of Cyanosis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Screening
Guidelines for the performance of fetal echocardiograms recommend:
- Color Doppler are used to identify small vessels such as the pulmonary veins, ductus venosus, and ductus arteriosus, to assess valvular competence and flow patterns, and to examine the ventricular septum for defects.
- Three-dimensional echocardiography, tissue Doppler, fetal electrocardiography, and cardiovascular magnetic resonance imaging. [14].
- When a fetal cardiac abnormality is detected, additional evaluation and follow-up are indicated.
- Patients who have a normal basic fetal cardiac evaluation and echocardiography generally do not require further evaluation unless there is an elevated risk of evolution of fetal heart disease later in pregnancy.
- Prenatal ultrasound and magnetic resonance imaging (MRI) found that brain abnormalities, delay in head growth, and brain-sparing were observed in subgroups of fetuses with congenital heart disease. 38
Genetic assessment
- Fetal genetic assessment is indicated because chromosome abnormalities are common in fetuses with cardiac defects, even when isolated.
- The risk of fetal aneuploidy varies depending on the malformation. [14]:
- The 22q11 deletion has been associated with several cardiac anomalies, including interrupted aortic arch, truncus arteriosus, ventricular septal defect, and tetralogy of Fallot. [14].
- The two main approaches for genetic testing are:
- G-banding of fetal cells obtained via amniocentesis, with fluorescent in situ hybridization (FISH) to assess for microdeletions, such as 22q11, not detectable by visual banding techniques.
- Chromosomal microarray, which detects submicroscopic chromosomal abnormalities in 5 percent of fetuses with ultrasound-detected anomalies and a normal G-band karyotype.
- Disadvantages of chromosomal microarray are that balanced rearrangements are not detectable and variants of unknown significance may be identified.